- Home
- CHPT vs LAB Comparison
CHPT vs LAB Comparison
Compare CHPT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- LAB
- Stock Information
- Founded
- CHPT 2007
- LAB 1999
- Country
- CHPT United States
- LAB United States
- Employees
- CHPT N/A
- LAB N/A
- Industry
- CHPT Industrial Specialties
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- CHPT Consumer Discretionary
- LAB Industrials
- Exchange
- CHPT Nasdaq
- LAB Nasdaq
- Market Cap
- CHPT 468.9M
- LAB 562.1M
- IPO Year
- CHPT N/A
- LAB 2011
- Fundamental
- Price
- CHPT $0.56
- LAB $1.16
- Analyst Decision
- CHPT Hold
- LAB Buy
- Analyst Count
- CHPT 10
- LAB 2
- Target Price
- CHPT $1.58
- LAB $2.50
- AVG Volume (30 Days)
- CHPT 19.9M
- LAB 1.3M
- Earning Date
- CHPT 06-04-2025
- LAB 05-07-2025
- Dividend Yield
- CHPT N/A
- LAB N/A
- EPS Growth
- CHPT N/A
- LAB N/A
- EPS
- CHPT N/A
- LAB N/A
- Revenue
- CHPT $417,083,000.00
- LAB $174,432,000.00
- Revenue This Year
- CHPT $12.71
- LAB N/A
- Revenue Next Year
- CHPT $27.42
- LAB $12.77
- P/E Ratio
- CHPT N/A
- LAB N/A
- Revenue Growth
- CHPT N/A
- LAB 64.03
- 52 Week Low
- CHPT $0.51
- LAB $0.97
- 52 Week High
- CHPT $2.44
- LAB $2.74
- Technical
- Relative Strength Index (RSI)
- CHPT 38.96
- LAB 50.69
- Support Level
- CHPT $0.56
- LAB $0.99
- Resistance Level
- CHPT $0.64
- LAB $1.18
- Average True Range (ATR)
- CHPT 0.05
- LAB 0.10
- MACD
- CHPT 0.00
- LAB 0.01
- Stochastic Oscillator
- CHPT 34.18
- LAB 86.36
About CHPT ChargePoint Holdings Inc.
ChargePoint designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.